Vienna - Delayed Quote EUR

Medtronic plc (MDT.VI)

85.31

+1.73

+(2.07%)

At close: January 17 at 5:32:33 PM GMT+1

BLS Data Shows Slowdown in Core CPI: Time to Buy MDT Stock Now?

Medtronic's strong liquidity position should allow it to meet its near-term debt obligations.

Zacks yesterday

MDT
Here's Why Medtronic (MDT) Gained But Lagged the Market Today

Medtronic (MDT) concluded the recent trading session at $85.40, signifying a +0.18% move from its prior day's close.

Zacks 2 days ago

MDT
CEO Geoff Martha tells JPM crowd Medtronic is ‘stacking growth drivers’

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, Martha said Monday at the J.P. Morgan Healthcare Conference.

MedTech Dive 4 days ago

MDT
CMS starts Medicare coverage analysis for Medtronic, Recor renal denervation devices

J.P. Morgan analysts said the CMS’ review “validates the technology and could potentially move the needle on growth for Medtronic.”

MedTech Dive 4 days ago

MDT
Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension. This national coverage analysis was initiated by CMS in response to Medtronic's request to support Medicare beneficiary access to t

PR Newswire 4 days ago

MDT
Medtronic nets CE mark for Parkinson’s adaptive deep brain stimulation system

Medtronic’s BrainSense aDBS is a therapy intended to improve the quality of life for individuals living with Parkinson’s disease.

Medical Device Network 4 days ago

MDT
Medtronic inks distribution deal with Contego with option to buy firm

Medtronic will be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes a carotid stent system and thrombectomy devices.

MedTech Dive 5 days ago

MDT
Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technology

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, announced today CE (Conformité Européenne) Mark approval in the European Union (EU) and the United Kingdom (UK) for BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™ Electrode Identifier (EI), having achieved the standards required by the EU Medical Device Regulation (MDR). In addition, the first programming was completed today, performed by Martijn Beudel, MD, PhD, neurologist and associate professor, Departmen

PR Newswire 5 days ago

MDT
3 Incredible Dividend Stocks to Buy in 2025

These wildly successful companies are poised to keep your dividend portfolio healthy in 2025 and beyond.

Motley Fool 7 days ago

MDT

ABBV

UNH
2 MedTech Stocks That Are Screaming Buys in January

At the intersection of healthcare and technology, medtech companies are leveraging innovative solutions to improve patient care and health outcomes. Industry leaders are well-positioned to deliver shareholder value by addressing the growing healthcare demands of an aging global population and the rising prevalence of chronic diseases. Recent breakthroughs in artificial intelligence (AI) and robotics have unlocked new growth opportunities, further supporting a robust long-term outlook.

Motley Fool 7 days ago

MDT

TMDX
Fire1 raises $120M to trial heart failure management system

Medtronic and Novo Holdings were among the investors in the funding round.

MedTech Dive 8 days ago

MDT
J&J Pauses Sales of Atrial Fibrillation Device, Stock Down

J&J's MedTech unit pauses all cases of the Varipulse PFA system as part of an external evaluation. Stock dips.

Zacks 8 days ago

JNJ

MDT

BSX
Medtronic inks exclusive deal to sell Kuros bone graft device

In the five-year agreement, Medtronic will be the exclusive sales agent for Kuros' product in certain U.S. spine geographies.

MedTech Dive 9 days ago

MDT
5 medtech trends to watch in 2025

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.

MedTech Dive 9 days ago

MDT

BSX
J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

Investor's Business Daily 9 days ago

JNJ

BSX

MDT
Is Medtronic's Dividend Safe?

For not just years but decades, Medtronic (NYSE: MDT) has proven to be a reliable dividend growth stock to own. Let's take a closer look at whether Medtronic's dividend is safe and if you can comfortably rely on its payout for the foreseeable future. A stock's payout ratio is a key metric that dividend investors will focus on when assessing if the payout is sustainable.

Motley Fool 9 days ago

MDT

^GSPC
1 Growth Stock Down 6% to Buy Right Now

You can break the stock market into different components, such as investing styles. Growth stocks have recently attracted investor interest. The Russell 3000 Growth Index returned 39.8% over the last year through Jan. 6.

Motley Fool 10 days ago

MDT
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025.

PR Newswire 11 days ago

MDT
Is Medtronic plc (NYSE:MDT) Among Israel Englander’s Top Stock Picks Heading Into 2025?

We recently compiled a list of the Billionaire Israel Englander’s Top 10 Stock Picks Heading Into 2025. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other stock picks. Israel Englander has always inspired the investment world by founding and managing the second-most profitable hedge fund in […]

Insider Monkey 12 days ago

MDT
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

If you're worried about having enough passive income to maintain your lifestyle during retirement, you're not alone. Filling your portfolio with dividend-paying stocks that raise their quarterly payouts faster than the underlying inflation rate could even lead to extra spending cash. Medtronic (NYSE: MDT), Bristol Myers Squibb (NYSE: BMY), and AbbVie (NYSE: ABBV) have many years of reliable dividend growth under their belts.

Motley Fool 14 days ago

ABBV

CELG-RT

MDT

Performance Overview

Return	MDT.VI	S&P 500
YTD	+10.58%	+1.52%
1-Year	+10.93%	+25.82%
3-Year	+0.15%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Medtronic plc (MDT.VI)

BLS Data Shows Slowdown in Core CPI: Time to Buy MDT Stock Now?

Here's Why Medtronic (MDT) Gained But Lagged the Market Today

CEO Geoff Martha tells JPM crowd Medtronic is ‘stacking growth drivers’

CMS starts Medicare coverage analysis for Medtronic, Recor renal denervation devices

Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System

Medtronic nets CE mark for Parkinson’s adaptive deep brain stimulation system

Medtronic inks distribution deal with Contego with option to buy firm

Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technology

3 Incredible Dividend Stocks to Buy in 2025

2 MedTech Stocks That Are Screaming Buys in January

Fire1 raises $120M to trial heart failure management system

J&J Pauses Sales of Atrial Fibrillation Device, Stock Down

Medtronic inks exclusive deal to sell Kuros bone graft device

5 medtech trends to watch in 2025

J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product

Is Medtronic's Dividend Safe?

1 Growth Stock Down 6% to Buy Right Now

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

Is Medtronic plc (NYSE:MDT) Among Israel Englander’s Top Stock Picks Heading Into 2025?

3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade

Performance Overview